NT-0249

CAS No. 2763617-39-4

NT-0249( —— )

Catalog No. M37576 CAS No. 2763617-39-4

NT-0249 is an orally active inhibitor of the inflammatory vesicle NLRP3 with anti-inflammatory activity that reverses high-fat diet-induced obesity, systemic inflammation, and astrocyte hyperplasia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 459 In Stock
10MG 657 In Stock
25MG 1026 In Stock
50MG 1386 In Stock
100MG 1832 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NT-0249
  • Note
    Research use only, not for human use.
  • Brief Description
    NT-0249 is an orally active inhibitor of the inflammatory vesicle NLRP3 with anti-inflammatory activity that reverses high-fat diet-induced obesity, systemic inflammation, and astrocyte hyperplasia.
  • Description
    NT-0249 is an orally active inhibitor of the inflammatory vesicle NLRP3 with anti-inflammatory activity that reverses high-fat diet-induced obesity, systemic inflammation, and astrocyte hyperplasia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    NF-κB
  • Target
    NOD
  • Recptor
    NOD
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2763617-39-4
  • Formula Weight
    481.54
  • Molecular Formula
    C22H28N5NaO4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [N-](C(NS(N(C[C@@H]1CCCO1)C2=CN(C)N=C2)(=O)=O)=O)C3=C4C(=CC5=C3CCC5)CCC4.[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BMS986299

    BMS986299 is a modulator of NLRP3 with an EC50 of 1.28 μM and can be used in studies about NLRP3 signaling and the treatment of associated diseases.

  • Asymmetric dimethyla...

    Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase (NOS).

  • Molsidomine

    Molsidomine is an orally active, long acting vasodilating drug, metabolized in the liver to the active metabolite linsidomine.